"The Impact of COVID-19 on Hypertrophic Cardiomyopathy Patients: Causes, Predictors, and Outcomes of 30-Day Readmission" by Zaid Abood, MD

Selected Works of Muhammad Fuad Jan, MD

Follow Contact

Presentation

The Impact of COVID-19 on Hypertrophic Cardiomyopathy Patients: Causes, Predictors, and Outcomes of 30-Day Readmission

Scientific Day

Zaid Abood, MD, Cardiovascular and Thoracic Services, Aurora St. Luke’s Medical Center, Advocate Health
M Fuad Jan, MBBS, MD, Interventional Cardiology, Aurora St. Luke’s Medical Center, Advocate Health
Arshad Jahangir, MD, Electrophysiology, Aurora St. Luke’s Medical Center, Advocate Health
A Jamil Tajik, MD, Cardiology, Aurora St. Luke’s Medical Center, Advocate Health

Download

Affiliations

Aurora Cardiovascular and Thoracic Services, Aurora St. Luke’s Medical Center

Presentation Notes

Presented at Scientific Day; May 22, 2024; Milwaukee, WI.

Full Text of Presentation

https://institutionalrepository.aah.org/cgi/viewcontent.cgi?article=1225&context=sciday

Document Type

Oral/Podium Presentation

Citation Information

Abood Z, Jan MF, Jahangir A, Tajik AJ. The Impact of COVID-19 on Hypertrophic Cardiomyopathy Patients: Causes, Predictors, and Outcomes of 30-Day Readmission. Presented at Scientific Day; May 22, 2024; Milwaukee, WI.